JMDC Inc. (TSE:4483) agreed to acquire Cancer Scan Co., Ltd. for ¥ 14000 million on December 28, 2023. JMDC Inc. (TSE:4483) will acquire 0.11 million shares of Cancer Scan Co., Ltd. The total assets were ¥ 2695 million, net assets were ¥ 2,097 million, revenue was ¥ 4,177 million, operating profit was ¥ 696 million and net income was ¥ 454 million for year ending May 31, 2023 of Cancer Scan Co., Ltd. The deal is expected to be closed on January 31, 2024.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3,412 JPY | +0.24% | +3.30% | -19.92% |
05-29 | Jefferies Adjusts JMDC’s Price Target to 4,800 Yen From 5,700 Yen, Keeps at Buy | MT |
05-08 | JMDC to Pay Final Dividend of 14 Yen Per Share in June | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.92% | 1.37B | |
-19.02% | 2.28B | |
+37.58% | 2.17B | |
+13.81% | 1.74B | |
-21.13% | 1.34B | |
-28.53% | 1.28B | |
-14.86% | 1B | |
-25.75% | 792M | |
+118.67% | 692M | |
+39.66% | 546M |
- Stock Market
- Equities
- 4483 Stock
- News JMDC Inc.
- JMDC Inc. agreed to acquire Cancer Scan Co., Ltd. for ¥ 14000 million.